Quantcast

Latest Merrimack Pharmaceuticals Inc. Stories

2015-04-28 16:28:48

CAMBRIDGE, Mass., April 28, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.

2015-04-21 08:35:49

Updated clinical data presented in an oral session at the 2015 American Association for Cancer Research Annual Meeting CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals,

2015-04-20 16:27:42

Median progression-free survival of 7.6 months reported for overall study population whose disease has progressed on a median of 4 prior therapies CAMBRIDGE, Mass., April 20, 2015 /PRNewswire/

2015-03-26 08:33:56

Phase 1 study of MM-302 will be presented in a plenary oral session CAMBRIDGE, Mass., March 26, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.

2015-03-09 08:29:47

HAYWARD, California, March 9, 2015 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc.

2014-05-01 08:34:14

MM-398 in Combination with 5-FU and Leucovorin Provides New Treatment Option for Patients Previously Treated with Gemcitabine MANHATTAN BEACH, Calif., May 1, 2014 /PRNewswire/ --


Word of the Day
coruscant
  • Emitting flashes of light; glittering.
The word 'coruscant' comes from a Latin word meaning 'to flash' or 'to sparkle'.
Related